Re­searchers call for fi­nan­cial in­cen­tives to speed con­fir­ma­to­ry tri­als for ac­cel­er­at­ed ap­provals

Bio­phar­ma com­pa­nies that win new ac­cel­er­at­ed ap­provals typ­i­cal­ly have no fi­nan­cial in­cen­tive to com­plete their con­fir­ma­to­ry tri­al be­cause the price of the treat­ment doesn’t change …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER